CYP3A4*22is related to increased plasma levels of 4-hydroxytamoxifen and partially compensates for reduced CYP2D6 activation of tamoxifen
出版年份 2015 全文链接
标题
CYP3A4*22is related to increased plasma levels of 4-hydroxytamoxifen and partially compensates for reduced CYP2D6 activation of tamoxifen
作者
关键词
-
出版物
PHARMACOGENOMICS
Volume 16, Issue 6, Pages 601-617
出版商
Future Medicine Ltd
发表日期
2015-04-20
DOI
10.2217/pgs.15.13
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Evaluation of Tamoxifen and Metabolites by LC-MS/MS and HPLC Methods
- (2016) D.D. Heath et al. BRITISH JOURNAL OF BIOMEDICAL SCIENCE
- Ultra-high performance liquid chromatography tandem mass spectrometric method for the determination of tamoxifen, N -desmethyltamoxifen, 4-hydroxytamoxifen and endoxifen in dried blood spots—Development, validation and clinical application during breast cancer adjuvant therapy
- (2015) Marina Venzon Antunes et al. TALANTA
- Tamoxifen dose and serum concentrations of tamoxifen and six of its metabolites in routine clinical outpatient care
- (2014) N. G. L. Jager et al. BREAST CANCER RESEARCH AND TREATMENT
- Population pharmacokinetic modelling to assess the impact of CYP2D6 and CYP3A metabolic phenotypes on the pharmacokinetics of tamoxifen and endoxifen
- (2014) Rob ter Heine et al. BRITISH JOURNAL OF CLINICAL PHARMACOLOGY
- Distribution of CYP2D6 Alleles and Phenotypes in the Brazilian Population
- (2014) Deise C. Friedrich et al. PLoS One
- CYP3A4 and seasonal variation in vitamin D status in addition to CYP2D6 contribute to therapeutic endoxifen level during tamoxifen therapy
- (2013) Wendy A. Teft et al. BREAST CANCER RESEARCH AND TREATMENT
- Association betweenCYP2D6genotypes and the clinical outcomes of adjuvant tamoxifen for breast cancer: a meta-analysis
- (2013) Jin-A Jung et al. PHARMACOGENOMICS
- Interplay between vitamin D and the drug metabolizing enzyme CYP3A4
- (2012) Zhican Wang et al. JOURNAL OF STEROID BIOCHEMISTRY AND MOLECULAR BIOLOGY
- Endoxifen Levels and Its Association With CYP2D6 Genotype and Phenotype
- (2012) Marina V. Antunes et al. THERAPEUTIC DRUG MONITORING
- Activity Levels of Tamoxifen Metabolites at the Estrogen Receptor and the Impact of Genetic Polymorphisms of Phase I and II Enzymes on Their Concentration Levels in Plasma
- (2011) T E Mürdter et al. CLINICAL PHARMACOLOGY & THERAPEUTICS
- Tamoxifen Metabolite Concentrations, CYP2D6 Genotype, and Breast Cancer Outcomes
- (2011) L Madlensky et al. CLINICAL PHARMACOLOGY & THERAPEUTICS
- Pharmacogenomics of CYP2D6: Molecular Genetics, Interethnic Differences and Clinical Importance
- (2011) Lay Kek Teh et al. Drug Metabolism and Pharmacokinetics
- Genotype-Guided Tamoxifen Dosing Increases Active Metabolite Exposure in Women With Reduced CYP2D6 Metabolism: A Multicenter Study
- (2011) William J. Irvin et al. JOURNAL OF CLINICAL ONCOLOGY
- Effect of a new functionalCYP3A4polymorphism on calcineurin inhibitors’ dose requirements and trough blood levels in stable renal transplant patients
- (2011) Laure Elens et al. PHARMACOGENOMICS
- Pharmacogenetics and forensic toxicology
- (2010) Frank Musshoff et al. FORENSIC SCIENCE INTERNATIONAL
- Composite Functional Genetic and Comedication CYP2D6 Activity Score in Predicting Tamoxifen Drug Exposure Among Breast Cancer Patients
- (2010) Silvana Borges et al. JOURNAL OF CLINICAL PHARMACOLOGY
- Intronic polymorphism in CYP3A4 affects hepatic expression and response to statin drugs
- (2010) D Wang et al. PHARMACOGENOMICS JOURNAL
- The CYP2D6*4 polymorphism affects breast cancer survival in tamoxifen users
- (2009) Monique J. Bijl et al. BREAST CANCER RESEARCH AND TREATMENT
- Pharmacogenomics of Tamoxifen Therapy
- (2009) H. Brauch et al. CLINICAL CHEMISTRY
- Association Between CYP2D6 Polymorphisms and Outcomes Among Women With Early Stage Breast Cancer Treated With Tamoxifen
- (2009) Werner Schroth JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Development and validation of a quantitative assay for the analysis of tamoxifen with its four main metabolites and the flavonoids daidzein, genistein and glycitein in human serum using liquid chromatography coupled with tandem mass spectrometry
- (2009) S.F. Teunissen et al. JOURNAL OF CHROMATOGRAPHY B-ANALYTICAL TECHNOLOGIES IN THE BIOMEDICAL AND LIFE SCIENCES
- Molecular diversity at theCYP2D6locus in healthy and schizophrenic southern Brazilians
- (2009) Fabiana B Kohlrausch et al. PHARMACOGENOMICS
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now